{"id":37194,"date":"2024-05-08T00:00:00","date_gmt":"2024-05-07T22:00:00","guid":{"rendered":"https:\/\/apte.org\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/"},"modified":"2025-09-11T09:51:28","modified_gmt":"2025-09-11T07:51:28","slug":"barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia","status":"publish","type":"post","link":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/","title":{"rendered":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia"},"content":{"rendered":"<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>The entrepreneurial community of the Barcelona Science Park, comprising nearly a hundred start-ups and scale-ups that promote innovation in biomedicine and life sciences, continues to grow steadily, attracting investment and strengthening its role as an essential asset for the sector&rsquo;s growth.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>According to the operations identified in&nbsp;<a href=&quot;https:\/\/report.biocat.cat\/&quot;>BioRegion of Catalonia 2023 report<\/a>, of the&nbsp;total capital invested in 2023 in the BioRegion (&euro;220 M),&nbsp;nearly&nbsp;40% (&euro;85.4 M) was concentrated in the Barcelona Science Park, which consolidates it as one of the most dynamic and forward-looking R&amp;D and health ecosystems in Europe.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Although this figure was lower than the&nbsp;<a href=&quot;https:\/\/www.pcb.ub.edu\/en\/barcelona-science-park-companies-break-record-after-raising-e142m-in-2022\/&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;142 million<\/a>&nbsp;obtained by start-ups and scale-ups linked to the Park during the historic 2022 &ndash; an exceptional year because three record-breaking mega-deals coincided in the BioRegion of Catalonia (<a href=&quot;https:\/\/www.pre.biocat.cat\/en\/record-funding-health-startups-based-catalonia-eu445-m-investment&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;445 M<\/a>) &ndash;&nbsp;the public and private funding received by these companies in 2023 is more than double the amount achieved in 2021&nbsp;(<a href=&quot;https:\/\/www.pcb.ub.edu\/en\/hallmark-barcelona-science-park-innovation\/&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;39 M<\/a>). This suggests that the Park&rsquo;s community continues to attract more investment, despite the difficult global geopolitical and economic environment.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Private funding (venture capital, private equity and venture debt) was the main source of investment (&euro;67.7 M), and&nbsp;almost quadruples the public funding&nbsp;achieved in regional, national and European competitive calls (&euro;17.7 M).<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>The participation of&nbsp;international capital&nbsp;in funding rounds continues its upward trend.&nbsp;Half of the 2023 deals involved foreign investors.&nbsp;Furthermore, the&nbsp;&euro;27.5 million&nbsp;in venture debt financing provided by the&nbsp;European Investment Bank (EIB)&nbsp;reflects its willingness to invest in new disruptive projects driven by start-ups and scale-ups with distinctive impact potential.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>The&nbsp;biotechnology&nbsp;and&nbsp;medical technology&nbsp;sub-sectors, with&nbsp;&euro;43.7 and&nbsp;&euro;24 million&nbsp;respectively,&nbsp;led the attraction of private investment in health. The most represented therapeutic areas were the nervous system, oncology and immunology. femtech, emerging technologies for women&rsquo;s health, and haematology are attracting increasing interest from investors.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Companies from the University of Barcelona Science Park community have obtained practically half of the financing raised by companies from the BioRegion of Catalonia. This fact, according to the director of the Barcelona Science Park,&nbsp;Maria Terrades, give a measure of &ldquo;the Park&rsquo;s relevance and position us as a key player and one of the epicentres of this powerful ecosystem.&rdquo; And he adds that, in fact, these results are proof that the investment sector and public institutions trust the Park entities and their future projection: &ldquo;we must continue to work with excellence so that these projects come full circle in our facilities.&rdquo;<\/span><\/span><\/p>\n<h3><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>The largest operation recorded in the BioRegion of Catalonia in 2023<\/span><\/span><\/h3>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Inbrain Neuroelectronics&nbsp;led the most important operation in terms of funding registered in the BioRegion of Catalonia last year. The ICN2 and ICREA spin-off &ndash; which has created the world&rsquo;s first graphene neural interface for the treatment of central nervous system (CNS) diseases &ndash; received a loan of&nbsp;<a href=&quot;https:\/\/www.eib.org\/en\/projects\/pipelines\/all\/20220924&quot;>&euro;20 million<\/a>&nbsp;from the European Investment Bank (EIB), with which it will accelerate the clinical development of its R&amp;D programmes for Parkinson&rsquo;s disease, epilepsy and speech disorders.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>SOM Biotech, specialised in the repositioning of drugs for CNS diseases, closed&nbsp;the third largest transaction&nbsp;(&euro;17 million) in the BioRegion of Catalonia with the EIB (<a href=&quot;https:\/\/www.eib.org\/en\/projects\/loans\/all\/20220519&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;7.5 million<\/a>), the US fund Prevail Partners and the current shareholders. The investment will be used to finance several ongoing projects: the phase IIb clinical trial of SOM3355 for Huntington&rsquo;s disease, and the initiation of trials with other molecules in diseases such as tardive dyskinesia (SOM3366) and phenylketonuria (SOM1311).<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Nuage Therapeutics&nbsp;took&nbsp;fourth place in the BioRegion of Catalonia, with the&nbsp;<a href=&quot;https:\/\/www.pcb.ub.edu\/nuage-therapeutics-capta-12-me-de-financament-llavor\/&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;12 million<\/a>&nbsp;obtained in a funding round led by Sofinnova Partners and Asabys, in which the CDTI (Innvierte programme) and Banc Sabadell (Bstartup) also participated. With this capital, the IRB Barcelona and ICREA spin-off aims to promote its project against prostate cancer and to validate its platform for the discovery of drugs that modulate intrinsically disordered proteins (IDPs).<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Among the group of companies that received between&nbsp;&euro;4 and 10 million&nbsp;in private funding are&nbsp;OneChain Immunotherapeutics&nbsp;(OCI),&nbsp;a clinical-stage biotech company focused on the development of CAR-T candidates for oncology diseases, which closed a pre-series A funding round of&nbsp;<a href=&quot;https:\/\/www.pcb.ub.edu\/en\/onechain-immunotherapeutics-secures-e6-7m-in-pre-series-a-funding-round\/&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;6.7 million<\/a>, and&nbsp;DeepUll, specialising in the development of affordable, culture-free diagnostic solutions for the early identification of sepsis and other acute infections, which received&nbsp;<a href=&quot;https:\/\/www.pcb.ub.edu\/sabadell-asabys-inverteix-en-deepull-ampliant-la-seva-ronda-de-financament-series-b-fins-als-17me\/&quot; rel=&quot;noopener&quot; target=&quot;_blank&quot;>&euro;4 million<\/a>&nbsp;which builds on the &euro;13 million from a series B funding round held in 2022.<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Among the start-ups and scale-ups that attracted between&nbsp;&euro;1 and 3 million&nbsp;in private equity are:&nbsp;Omniscope&nbsp;(&euro;1.8 million),&nbsp;Zymvol&nbsp;(1,3 M&euro;),&nbsp;MiMark Diagnostics&nbsp;(&euro;1.7 million) and&nbsp;IDP Pharma&nbsp;(&euro;1.1 million). Other companies that also received a capital injection in 2023 are&nbsp;Pharmacelera&nbsp;(&euro;922,000),&nbsp;Kumux&nbsp;(&euro;500,000) and&nbsp;Connecta Therapeutics&nbsp;(&euro;200,000).<\/span><\/span><\/p>\n<h3><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>A leading hub for attracting public investment in health<\/span><\/span><\/h3>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>The public funding received by the companies of the Barcelona Science Park community in 2023 reached&nbsp;&euro;17.7 million, mainly from the European Commission -through various instruments of the European Innovation Council (EIC)- and from the NextGenerationEU fund, through Spain&rsquo;s National Recovery and Resilience Plan (NRRP).<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>At the top of the ranking is the biotech&nbsp;OneChain&nbsp;(&euro;3.8 M),&nbsp;MiMARK Diagnostics&nbsp;(&euro;3 M),&nbsp;GAT Biosciences&nbsp;(2,2 M&euro;),&nbsp;Leanbio&nbsp;(2,1 M&euro;) and&nbsp;Connecta Therapeutics&nbsp;(2 M&euro;).<\/span><\/span><\/p>\n<p><span style=&quot;font-size:16px;&quot;><span style=&quot;font-family:Arial,Helvetica,sans-serif;&quot;>Several start-ups and scale-ups at the Park significantly expanded their financial capacity through competitive regional, national and European calls for proposals:&nbsp;Nuage Therapeutics&nbsp;(&euro;861,000),&nbsp;Vitala Technologies&nbsp;(&euro;704.000),&nbsp;Accure Therapeutics&nbsp;(&euro;656.000),&nbsp;Pharmacelera&nbsp;(&euro;600.000),&nbsp;Bioliquid Innovative Genetics&nbsp;(&euro;500.000 &euro;),&nbsp;Innerva Bioelectronics&nbsp;(&euro;416.000 &euro;),&nbsp;Aptadel Therapeutics&nbsp;(&euro;325.000 &euro;) and&nbsp;Real Deal Milk&nbsp;(&euro;324.000 &euro;).&nbsp;SiTec PharmaBio,&nbsp;Gate2Brain&nbsp;and&nbsp;Cytes Biotechnologies&nbsp;also obtained public funding in 2023.<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parc Cient\u00edfic de Barcelona<\/p>\n","protected":false},"author":1,"featured_media":37019,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1092],"tags":[],"class_list":["post-37194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-park-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia\" \/>\n<meta property=\"og:description\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/\" \/>\n<meta property=\"og:site_name\" content=\"APTE\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T22:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-11T07:51:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin_solbyte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_solbyte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/\"},\"author\":{\"name\":\"admin_solbyte\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/#\\\/schema\\\/person\\\/b088e98ec16e7b8567544de9564df77a\"},\"headline\":\"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia\",\"datePublished\":\"2024-05-07T22:00:00+00:00\",\"dateModified\":\"2025-09-11T07:51:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/\"},\"wordCount\":1037,\"image\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.apte.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg\",\"articleSection\":[\"Park news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/\",\"url\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/\",\"name\":\"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.apte.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg\",\"datePublished\":\"2024-05-07T22:00:00+00:00\",\"dateModified\":\"2025-09-11T07:51:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/#\\\/schema\\\/person\\\/b088e98ec16e7b8567544de9564df77a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.apte.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.apte.org\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.apte.org\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.apte.org\\\/en\\\/\",\"name\":\"APTE\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.apte.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.apte.org\\\/en\\\/#\\\/schema\\\/person\\\/b088e98ec16e7b8567544de9564df77a\",\"name\":\"admin_solbyte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g\",\"caption\":\"admin_solbyte\"},\"sameAs\":[\"https:\\\/\\\/apte.org\"],\"url\":\"https:\\\/\\\/www.apte.org\\\/en\\\/author\\\/admin_solbyte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/","og_locale":"en_US","og_type":"article","og_title":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia","og_description":"Parc Cient\u00edfic de Barcelona","og_url":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/","og_site_name":"APTE","article_published_time":"2024-05-07T22:00:00+00:00","article_modified_time":"2025-09-11T07:51:28+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg","type":"image\/jpeg"}],"author":"admin_solbyte","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_solbyte","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#article","isPartOf":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/"},"author":{"name":"admin_solbyte","@id":"https:\/\/www.apte.org\/en\/#\/schema\/person\/b088e98ec16e7b8567544de9564df77a"},"headline":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia","datePublished":"2024-05-07T22:00:00+00:00","dateModified":"2025-09-11T07:51:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/"},"wordCount":1037,"image":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg","articleSection":["Park news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/","url":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/","name":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia","isPartOf":{"@id":"https:\/\/www.apte.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#primaryimage"},"image":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg","datePublished":"2024-05-07T22:00:00+00:00","dateModified":"2025-09-11T07:51:28+00:00","author":{"@id":"https:\/\/www.apte.org\/en\/#\/schema\/person\/b088e98ec16e7b8567544de9564df77a"},"breadcrumb":{"@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#primaryimage","url":"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg","contentUrl":"https:\/\/www.apte.org\/wp-content\/uploads\/2025\/06\/las-empresas-del-parque-cientifico-de-barcelona-levantan-854-mE-en-2023-un-40-del-total-captado-en-la-bioregion-de.jpeg","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.apte.org\/en\/barcelona-science-park-companies-receive-85-investment-total-bioregion-catalonia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.apte.org\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Barcelona Science Park companies receive \u20ac85.4 million in investment in 2023, 40% of the total in the BioRegion of Catalonia"}]},{"@type":"WebSite","@id":"https:\/\/www.apte.org\/en\/#website","url":"https:\/\/www.apte.org\/en\/","name":"APTE","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.apte.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.apte.org\/en\/#\/schema\/person\/b088e98ec16e7b8567544de9564df77a","name":"admin_solbyte","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3205173b7398583b17f637a874b58ff7fea99c92c05aa474ff0fdc03de0c3e91?s=96&d=mm&r=g","caption":"admin_solbyte"},"sameAs":["https:\/\/apte.org"],"url":"https:\/\/www.apte.org\/en\/author\/admin_solbyte\/"}]}},"_links":{"self":[{"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/posts\/37194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/comments?post=37194"}],"version-history":[{"count":1,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/posts\/37194\/revisions"}],"predecessor-version":[{"id":46849,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/posts\/37194\/revisions\/46849"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/media\/37019"}],"wp:attachment":[{"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/media?parent=37194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/categories?post=37194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.apte.org\/en\/wp-json\/wp\/v2\/tags?post=37194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}